Search results
Scientists report longest known ‘extreme’ Covid infection in 72-year-old man
The Independent via Yahoo News· 2 weeks agoHowever, there has been no documented transmission of the highly mutated virus variant to other...
New technology uncovers mechanism affecting generation of new COVID variants
Medical Xpress· 2 weeks agoUsing tARC-seq, the researchers also captured new mutations in SARS-CoV-2 in infected cells in the lab that recapitulated observations ...
Data: Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days
Center for Infectious Disease Research and Policy· 2 weeks agoTaking the SARS-CoV-2 antiviral drug nirmatrelvir-ritonavir (Paxlovid) 3 to 5 days after COVID-19...
Antibiotic neomycin may protect against the flu, COVID-19
Medical News Today· 1 week agoViral respiratory infections are common and generally result in a few days of illness from which...
RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035
WTNH-TV New Haven· 3 hours ago...RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the issue of a new Chinese patent Notice of Allowance covering opaganib[1] as a therapyg for inhibition of single-stranded RNA virus replication (notably Ebola Disease Virus) from the Chinese National...
COVID-19 Proteins Can Hang Around In The Blood For Up To 14 Months After Infection
IFLScience· 7 days agoThe idea that SARS-CoV-2, the virus behind COVID-19, may be able to persist in the body long after...
Optimal timing maximizes Paxlovid benefits for treating COVID-19
Medical Xpress· 2 weeks agoResearchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife ...
A better COVID treatment for the immunocompromised? Researchers create a non-toxic potential...
Medical Xpress· 6 days agoPeople who are infected with SARS-CoV-2, the virus that causes COVID-19, currently have two options...
Study finds metformin reduces COVID-19 viral load, viral rebound
Medical Xpress· 4 days agoThe study was published in Clinical Infectious Diseases. A higher viral load—the amount of virus in...
Yale-led team develops potential non-toxic alternative to Paxlovid
Newswise· 2 weeks agoPaxlovid (Nirmatrelvir/ritonavir) has been instrumental in treating COVID-19 infections, but negative interactions between ritonavir and other drugs have led some patients to be hospitalized ...